OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
UNX.ASE55

Unigel Group PLC

Commodity ChemicalsVerified

Unigel Group PLC maintains a conservative capital structure, with a debt-to-equity ratio of 0.2, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium risk, with a current ratio of 1.44, suggesting it has sufficient short-term assets to cover its short-term liabilities, but not with a large margin of safety. The company reported a free cash flow of GBP 1,810,030, which supports its ability to fund operations and potentially return value to shareholders. In terms of profitability, Unigel Group PLC reported a return on equity (ROE) of 33.73% and a return on assets (ROA) of 13.14%, both of which are strong indicators of efficient use of equity and assets. These figures are well above the typical thresholds for the commodity chemicals industry, suggesting the company is outperforming its peers in terms of capital efficiency and profitability. The company's revenue is concentrated within a single disclosed segment, with no geographic breakdown provided in the latest financial data. This lack of diversification may expose the company to regional economic or regulatory risks, though the extent of such exposure is not quantified in the available data. Looking ahead, Unigel Group PLC is expected to maintain a stable growth trajectory, with no significant changes in revenue or operating performance projected in the next fiscal year. The company's capital expenditure was negative GBP 68,550, indicating a reduction in investment in physical assets, which may reflect a focus on cost optimization or a mature stage of operations. The company's risk profile is characterized by a low dilution potential, with no significant dilution events expected in the near term. The risk assessment indicates that the company's net cash position is negative after subtracting total debt, which could pose a liquidity risk if not managed effectively. Recent filings and transcripts do not indicate any material events or strategic shifts for Unigel Group PLC. The company appears to be operating within a stable business environment, with no major disruptions or regulatory changes reported in the latest available data.

30-day price · UNX.ASE-27.50 (-31.4%)
Low$50.00High$90.00Close$60.00As of17 May, 00:00 UTC
Profile
CompanyUnigel Group PLC
TickerUNX.ASE
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Unigel Group PLC is a chemicals company that operates in the commodity chemicals industry, generating revenue primarily through the production and sale of chemical products.

Classification. Unigel Group PLC is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Unigel Group PLC maintains a conservative capital structure, with a debt-to-equity ratio of 0.2, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium risk, with a current ratio of 1.44, suggesting it has sufficient short-term assets to cover its short-term liabilities, but not with a large margin of safety. The company reported a free cash flow of GBP 1,810,030, which supports its ability to fund operations and potentially return value to shareholders. In terms of profitability, Unigel Group PLC reported a return on equity (ROE) of 33.73% and a return on assets (ROA) of 13.14%, both of which are strong indicators of efficient use of equity and assets. These figures are well above the typical thresholds for the commodity chemicals industry, suggesting the company is outperforming its peers in terms of capital efficiency and profitability. The company's revenue is concentrated within a single disclosed segment, with no geographic breakdown provided in the latest financial data. This lack of diversification may expose the company to regional economic or regulatory risks, though the extent of such exposure is not quantified in the available data. Looking ahead, Unigel Group PLC is expected to maintain a stable growth trajectory, with no significant changes in revenue or operating performance projected in the next fiscal year. The company's capital expenditure was negative GBP 68,550, indicating a reduction in investment in physical assets, which may reflect a focus on cost optimization or a mature stage of operations. The company's risk profile is characterized by a low dilution potential, with no significant dilution events expected in the near term. The risk assessment indicates that the company's net cash position is negative after subtracting total debt, which could pose a liquidity risk if not managed effectively. Recent filings and transcripts do not indicate any material events or strategic shifts for Unigel Group PLC. The company appears to be operating within a stable business environment, with no major disruptions or regulatory changes reported in the latest available data.
Key takeaways
  • Unigel Group PLC has a strong return on equity and return on assets, indicating efficient use of capital and assets.
  • The company maintains a conservative debt-to-equity ratio, suggesting a low financial leverage risk.
  • Free cash flow is positive, supporting operational flexibility and potential shareholder returns.
  • The company's liquidity position is moderate, with a current ratio of 1.44.
  • Revenue is concentrated in a single segment, with no geographic diversification disclosed.
  • No significant dilution risk is expected in the near term.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue$29.2M
Gross profit$5.9M
Operating income$2.1M
Net income$1.7M
R&D
SG&A
D&A
SBC
Operating cash flow$1.0M
CapEx-$68.5k
Free cash flow$1.8M
Total assets$12.7M
Total liabilities$7.7M
Total equity$4.9M
Cash & equivalents
Long-term debt$994.4k
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$4.9M
Net cash-$994.4k
Current ratio1.4
Debt/Equity0.2
ROA13.1%
ROE33.7%
Cash conversion60.0%
CapEx/Revenue-0.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricUNX.ASEActivity
Op margin7.1%0.4% medp25 -8.0% · p75 16.0%above median
Net margin5.7%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin20.2%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity20.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 20:12 UTC#6d5a2ecd
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 20:13 UTCJob: 5666ca89